Novosibirsk State Pedagogical University Bulletin, 2014, No.5, pp.127-136
UDC: 
616.13-004.6:616.153.915

Components of the metabolic syndrome at patients with the multifocal atherosclerosis

Khaybullina Z. R. 1 (Tashkent, Uzbekistan, Republic of Uzbekistan)
1 Republican specialized centre of surgery named after academician V.Vakhidov
Abstract: 

The article is devoted to studying of components of a metabolic syndrome at patients with multifocal atherosclerosis (MFA). Changes of lipid’s, carbohydrate’s metabolism parameters, markers of a system inflammation and oxidizing stress are analyzed at patients with MFA, including atherosclerotic damage in various arterial pools (carotid, coronary, iliac-femoral) and it’s combinations. Materials and methods of research included the analysis of the clinic and laboratory data at 84 patients with a peripheral and multifocal atherosclerosis. It is established, that at a peripheral atherosclerosis of the main arteries of a leg (AMAL) from components of metabolic syndrome (MS) most frequently observed hyperthreeglyceridemia without obesity. Arterial hypertension and hyperthreeglyceridemia observed at MFA, including carotid arteries damage; obesity and hypercholesterolemia were at patients with stenosis / occlusion of coronary and carotid arteries without atherosclerosis in iliac-femoral vessels. Presence of full cluster of MS observed in 60 % of cases at patients with damage of 3 arterial pools, whereas at patients with AMAL ( damage of 1 arterial pool) it was only in 30 % of cases, that half is less, than at MFA. It specifies the high importance of adverse influence of MS components to MFA progression. It was established, MFA, including carotid and coronary arteries it is accompanied by a high level of oxidizing stress, probably, due to the high sensitivity of brain and heart tissues to hypoxia and vulnerability from toxic effects of reactive oxygen species. At patients with coronary and carotids atherosclerosis the oxidizing stress was closely connected to an inflammation: correlation between C-reactive protein and malondialdehyde levels has made (r=82, p > 0,05). For MFA, including coronary arteries damage the prevalence of oxidizing stress was established, at MFA with AMAL the inflammation was more expressed. Inflammation and oxidizing stress are factors of development and progressing of MFA.

Keywords: 

multifocal atherosclerosis, peripheral atherosclerosis of the main arteries of a leg, metabolic syndrome, inflammation, oxidizing stress, hypertrigliceridemia

For citation:
Khaybullina Z. R., Kosnikova I. V. Components of the metabolic syndrome at patients with the multifocal atherosclerosis. Novosibirsk State Pedagogical University Bulletin, 2014, no. 5, pp. 127–136.

References: 
  1. Mit'kovskaja N. P., Grigorenko E. A., Patekzh I. V., Statkevich T. V., Kurak T. A., Terehov V. I., Shved M. V., Shumskaya E. N. Early diagnostics of an atherosclerosis (lecture). Cardiology in Belorussia. 2012, n. 6 (25), pp. 134–155. (In Russian)
  2. Avilova M. V., Cosmacheva E. D. Multifocal an atherosclerosis: a problem of complex  atherosclerotic defeat of coronary and brachicephalic arterial pools.  Creative cardiology. 2013, n. 1,
    pp. 5–13. (In Russian)
  3. Ivchenko O. A. Kliniko-pathogenetic bases of methods of correction of Lerish syndrome  and atherosclerotic occlusions of arteries of the legs. bottom finitenesses. Moscow, 1990. (In Russian)
  4. Pasechnik A. V., Moiseeva E. G., Frolov V. A., Drozdova G. A. Inflammation and metabolic damage. The manual. Moscow, 2011. (In Russian)
  5. Huang P. L. A comprehensive definition for metabolic syndrome. Disease model & mechanisms. 2009, n. 2, pp. 231–237.
  6. Gaisenok O. V., Deev A. D., Mazaev V. P., et al. The role of the known risk factors as predictors of detection atherosclerotic lesion of coronary and carotid arteries. Preventive medicine. 2012,
    n. 15 (2), pp. 30.
  7. WHO Report on the Global Tobacco Epidemic: Warning about the dangers of tobacco. 2012. Accessed: http://whqlibdoc.who.int/hq/2011/WHO_NMH_TFI_11.3_eng.pdf webcite (available at: 13.04.2014)
  8. Khaybullina Z. R., Kosnikova I. V. Metabolic disorders at patients with ischemic heart disease at various types of myocardium vascularization disturbances.Universum: Medicine and fharmacology. Electron scientific journal. 2014, n. 4 (5).  Accessed: http://7universum.com/ru/med/archive/item/1226 (available at: 13.04.2014) (In Russian)
  9. Ragino JU. I. Factor and mechanisms of a coronary atherosclerosis and its complications. Atherosclerosis. 2012, n. 1, pp. 61–65. (In Russian)
  10. Gavrilova N. E., Metel'skaja V. A., Perova N. V., Yarovaya  E. B., Mazaev V. P., Urazalina S. Z., Boytsov S. A. Interrelation between expressiveness of a coronary atherosclerosis, risk factors and markers of atherosclerotic damage of carotid and peripheral arteries. Cardiovascular therapy and prevention. 2013, n. 12 (1), pp. 40–45. (In Russian)
  11. Stolar M. Metabolic syndrome: Controversial but useful.  Cleveland clinic journal of medicine. 2007, n. 74 (3), pp. 199–208.
  12. Pohjantahti-Maaroos H., Palomaki A. Comparison of metabolic syndrome subjects with and without erectile dysfunction – levels of circulating oxidised LDL and arterial elasticity. International Journal of Clinical Practise. 2011, n. 65, pp. 274–280.
  13. Thomas N., Phillips A. C., Carroll D. The metabolic syndrome adds utility to prediction of mortality over its components.  Atherosclerosis.2009. n. 210, pp. 256–261.  http://dx.doi.org/10.1016/j.atherosclerosis.2009.10.045 (available at: 13.04.2014)
Date of the publication 25.10.2014